Losartan Cost in Rhode Island 2026

What Losartan Is and Why Cost Matters in Rhode Island

Losartan is an angiotensin II receptor blocker (ARB) approved by the FDA for three indications: hypertension, reduction of stroke risk in patients with left ventricular hypertrophy, and slowing the progression of diabetic nephropathy in patients with type 2 diabetes [1]. It blocks the AT1 receptor, lowering systemic vascular resistance without the cough that makes ACE inhibitors intolerable for roughly 10 to 15% of patients [2].

Rhode Island's adult hypertension prevalence sits at approximately 33%, consistent with the national figure tracked by the CDC [3]. With more than 1 million residents, tens of thousands of Rhode Islanders fill ARB prescriptions every year. Because losartan is a long-term, once-daily therapy, even modest monthly price differences compound into hundreds of dollars annually. That makes price transparency genuinely useful for patients and prescribers.

The LIFE trial (N=9,193, Lancet 2002) showed losartan 50 to 100 mg reduced the composite endpoint of cardiovascular death, stroke, and myocardial infarction by 13% compared with atenolol in patients with hypertension and left ventricular hypertrophy (RR 0.87 to 95% CI 0.77, 0.98, P=0.021) [4]. That evidence base anchors its continued prominence in treatment guidelines and formularies. The American Heart Association and American College of Cardiology 2017 hypertension guideline lists ARBs as first-line agents for hypertension in patients with chronic kidney disease, heart failure, or diabetes [5].

According to the FDA-approved prescribing information for losartan potassium, the drug is indicated "to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy" and is available in 25 mg, 50 mg, and 100 mg tablets [1].

Generic vs. Brand-Name Losartan: The Price Gap in Rhode Island

Generic losartan is dramatically cheaper than brand-name Cozaar. At Rhode Island retail pharmacies in 2026, the average cash price for a 30-day supply of generic losartan 50 mg is approximately $10. Brand-name Cozaar carries a manufacturer list price near $80 per month [6].

Generic losartan was first approved by the FDA in 2010 after Merck's patent exclusivity expired [7]. Multiple manufacturers now supply the market, including Teva, Aurobindo, and Torrent, which sustains competitive pricing. The FDA's Orange Book lists all currently approved generic losartan formulations and their bioequivalence data [7].

The difference between $10 and $80 is not academic. A patient paying cash for brand-name Cozaar spends $840 more per year than one buying generic. For a patient on a fixed income in Rhode Island, that delta is clinically meaningful because non-adherence driven by cost is one of the most common causes of uncontrolled hypertension [8]. Research published in JAMA Internal Medicine found that each 10% increase in out-of-pocket drug costs corresponds to a roughly 3% reduction in adherence to antihypertensive therapy [8].

Ask your pharmacist specifically for "generic losartan potassium" when dropping off a prescription. Some pharmacy systems default to brand unless the patient or prescriber requests otherwise.

Rhode Island Medicaid and Losartan Coverage

Rhode Island Medicaid covers losartan with prior authorization (PA). The PA requirement exists because Medicaid preferred drug lists (PDLs) in many states tier ARBs by clinical indication, favoring certain generics or requiring documentation that ACE inhibitors were tried and failed or were contraindicated [9].

The Rhode Island Executive Office of Health and Human Services administers Medicaid and publishes its PDL through the RI Medicaid program [9]. For a prescriber to obtain PA approval, the standard process involves submitting clinical notes documenting the indication (hypertension, diabetic nephropathy, or LVH-related stroke risk reduction), any prior therapies, and contraindications to alternatives. The process typically takes 24 to 72 hours for standard PA and can be expedited for urgent cases.

Rhody Health Partners, Neighborhood Health Plan of Rhode Island, and UnitedHealthcare Community Plan are the three managed care organizations (MCOs) contracted with RI Medicaid as of 2025 [9]. Each MCO maintains its own formulary, though all must comply with the state PDL. A patient switching MCOs mid-year may need a new PA. Patients enrolled in the Rhode Island Prescription Drug Program (RIPDP) for the uninsured or underinsured may access losartan at reduced cost as well [9].

The National Academy for State Health Policy tracks Medicaid ARB coverage across all 50 states, and RI's PA requirement is consistent with the majority of state Medicaid programs [10].

Commercial Insurance Tiers for Losartan in Rhode Island

Most commercial insurance plans in Rhode Island place generic losartan on Tier 1 or Tier 2. Tier 1 drugs typically carry a $0, $10 copay; Tier 2 drugs carry a $15, $45 copay depending on the plan design.

Blue Cross Blue Shield of Rhode Island, Tufts Health Plan, and Aetna are among the largest commercial insurers operating in the state. All three list generic losartan as a preferred generic on their 2025 to 2026 formularies [11]. Patients can verify their specific tier and copay using the formulary search tool on each insurer's member portal or by calling the member services number on their insurance card.

For employer-sponsored plans governed by ERISA, the formulary may differ from the insurer's individual-market product. If your plan places losartan on Tier 3, ask your prescriber to submit a formulary exception request citing the FDA label, LIFE trial data, and AHA/ACC guideline recommendation [4][5]. Exception approvals move losartan to the lower tier for the remainder of the plan year in most cases.

Medicare Part D plans available in Rhode Island in 2026 also generally cover generic losartan on Tier 1 or Tier 2. The Medicare Plan Finder at CMS.gov allows beneficiaries to compare specific plan costs [12].

Discount Programs and Savings Cards for Losartan in Rhode Island

Several programs can reduce or eliminate out-of-pocket costs for losartan in Rhode Island, regardless of insurance status.

GoodRx and similar platforms. GoodRx, RxSaver, and Blink Health negotiate discount rates with pharmacy chains. At major Rhode Island pharmacies including CVS, Walgreens, and Walmart, GoodRx prices for generic losartan 50 mg (30 tablets) range from about $4 to $14 depending on the specific store and NDC [13]. These are cash-pay discount prices and cannot be combined with insurance in most cases.

Merck Patient Assistance Program. For the brand-name product Cozaar, Merck offers the Merck Patient Assistance Program for uninsured or underinsured patients who meet income criteria [14]. Eligibility is income-based, typically requiring household income at or below 400% of the federal poverty level. Applications are submitted at merckhelps.com or through a prescriber's office.

NeedyMeds. NeedyMeds catalogs both manufacturer programs and state pharmaceutical assistance programs. Rhode Island does not currently operate a separate state senior pharmaceutical program equivalent to some other states, so patients relying on state programs are directed primarily to RI Medicaid and RIPDP [15].

$4 generic programs. Walmart, Costco, and some independent Rhode Island pharmacies participate in $4 generic programs that include losartan. These programs bypass insurance entirely and are useful for patients with high-deductible plans early in the calendar year [13].

Compounded Losartan in Rhode Island: Legality and Cost

Compounded losartan is legal in Rhode Island when prepared by a 503A pharmacy operating under a valid patient-specific prescription from a licensed prescriber. The FDA's 503A framework permits licensed compounding pharmacies to prepare individualized formulations that are not commercially available or that address a documented clinical need, such as an alternative dosage form [16].

Rhode Island's Board of Pharmacy licenses and inspects compounding pharmacies under state law and in coordination with federal FDA oversight [17]. A 503A pharmacy in Rhode Island may compound losartan in custom doses or alternative delivery forms (such as oral suspension for pediatric patients or patients with swallowing difficulty) based on a valid prescription.

Compounded losartan is NOT a FDA-approved drug product. It does not carry the same bioequivalence data as generic losartan approved through the ANDA process [16]. Prescribers and patients should understand that distinction.

Cost for compounded losartan varies by pharmacy and formulation. Under some telehealth or direct-primary-care arrangements, the cost to the patient may be $0 per month if the compounding pharmacy fee is bundled into a membership or provider fee. Patients should ask explicitly whether the quoted cost is all-inclusive and whether the compounding pharmacy holds a valid RI Board of Pharmacy license.

The FDA's guidance on 503A compounding outlines exactly which conditions justify compounding a commercially available drug: the prescriber must document a specific patient need that the commercial product cannot meet [16].

Telehealth Prescribing of Losartan in Rhode Island

Telehealth prescribing of losartan is legal in Rhode Island. Rhode Island joined the Interstate Medical Licensure Compact (IMLC) and maintains telehealth prescribing rules consistent with federal and state controlled-substance laws [18]. Losartan is not a controlled substance, so no DEA-specific restrictions apply.

A licensed physician, nurse practitioner, or physician assistant with a valid Rhode Island license may prescribe losartan via a synchronous video visit or, depending on platform and clinical context, an asynchronous evaluation. The standard of care requires a documented patient-provider relationship with appropriate history, blood pressure measurement (self-reported or remote), and review of relevant labs (e.g., serum creatinine, potassium) before initiating or continuing therapy [18].

The American Telemedicine Association notes that telehealth blood pressure management programs produce adherence rates comparable to in-person care for stable, established patients [19]. For new patients, most RI telehealth providers require at least one synchronous encounter before prescribing antihypertensives.

After a telehealth visit, the prescription can be transmitted electronically to any RI pharmacy or to a mail-order pharmacy, including PillPack (Amazon Pharmacy), which serves Rhode Island residents.

How to Get the Lowest Price on Losartan in Rhode Island: A Practical Framework

The following decision path reflects HealthRX clinical team guidance for Rhode Island patients seeking the lowest total cost for losartan in 2026:

Step 1: Confirm generic. Verify your prescription reads "losartan potassium, generic substitution permitted." This single step eliminates the $80 brand-name price immediately.

Step 2: Check your formulary tier. Log into your insurance member portal and search for losartan. If it is Tier 1 or Tier 2, use your insurance. If it is Tier 3 or higher, proceed to Step 3 before requesting a formulary exception.

Step 3: Compare cash-pay discount prices. Run the NDC for losartan potassium 50 mg on GoodRx or RxSaver at your preferred pharmacy. If the discount price ($4, $14) is lower than your insurance copay, use the discount card instead of insurance for that fill.

Step 4: Evaluate $4 generic programs. If you fill at Walmart, Costco, or a participating independent RI pharmacy, ask whether losartan is on their internal $4 program. No app or card is needed.

Step 5: Consider mail order. Most insurance plans offer a 90-day mail-order supply for the cost of two monthly copays, effectively giving one month free. Amazon Pharmacy and Costco Pharmacy ship to Rhode Island addresses.

Step 6: Apply for assistance if uninsured. If you have no insurance and do not qualify for RI Medicaid, apply to NeedyMeds, the Merck Patient Assistance Program, or enroll in RIPDP [14][15].

A patient who follows Steps 1 through 4 should pay no more than $10 per month at a Rhode Island retail pharmacy, and potentially as little as $4.

Clinical Context: Dosing, Monitoring, and Safety

Understanding cost is only useful if the patient is on the right dose. The FDA-approved dosing range for losartan is 25 to 100 mg once daily by mouth. Most patients with hypertension start at 50 mg once daily; the dose may be increased to 100 mg if the blood pressure response is inadequate after 3 to 6 weeks [1].

For patients with diabetic nephropathy, the RENAAL trial (N=1,513) demonstrated that losartan 50 to 100 mg reduced the risk of doubling of serum creatinine, end-stage renal disease, or death by 16% compared with placebo (P=0.022) over a mean follow-up of 3.4 years [20]. Those patients require monitoring of serum creatinine and serum potassium at baseline, at 1 to 2 weeks after initiation or dose change, and then every 3 to 6 months when stable [20].

Contraindications include concomitant use with aliskiren in patients with diabetes (risk of hypotension, hyperkalemia, and renal impairment) and pregnancy (all trimesters, FDA category D/X) [1]. The FDA safety label warns specifically that "drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus" [1].

Common adverse effects include hyperkalemia, dizziness, and a rise in serum creatinine. Unlike ACE inhibitors such as lisinopril, losartan does not cause bradykinin-mediated cough, which makes it a preferred alternative for roughly 10% of patients who develop ACE inhibitor cough [2]. A 2020 Cochrane review of ARBs vs. ACE inhibitors confirmed the cough incidence difference (ARB cough rate ~2% vs. ACE inhibitor ~10%, risk ratio 0.17 to 95% CI 0.12, 0.24) [2].

Blood pressure targets according to the 2017 AHA/ACC guideline: below 130/80 mmHg for most adults, and below 130/80 mmHg for patients with diabetes or chronic kidney disease [5]. If losartan 100 mg once daily does not achieve that target, the guideline recommends adding a second agent such as a thiazide diuretic or calcium channel blocker rather than switching ARBs [5].

Patients should be counseled to avoid high-potassium foods in excess (bananas, oranges, potatoes) during initiation, and to avoid NSAIDs chronically because they blunt the antihypertensive effect of ARBs and increase the risk of acute kidney injury [1][21]. A prospective cohort study in BMJ (2013, N=500,000 person-years) found that concurrent NSAID and ARB use increased acute kidney injury hospitalization risk by 31% compared with either drug alone [21].

Rhode Island-Specific Resources and Access Points

Rhode Island has a relatively dense primary care and pharmacy infrastructure compared with rural states. CVS Health is headquartered in Woonsocket, RI, and CVS pharmacies have the widest footprint in the state.

Key RI access points for losartan:

Retail chains: CVS, Walgreens, Walmart (North Providence, Warwick, Middletown), Rite Aid, and Stop and Shop pharmacies.

Independent pharmacies: Village Pharmacy (Providence), Family Pharmacy (Cranston), and community health center pharmacies associated with Providence Community Health Centers.

Mail order: Express Scripts, CVS Caremark, Optum Rx, and Amazon Pharmacy all ship to Rhode Island ZIP codes.

Telehealth platforms licensed in RI: HealthRX, Teladoc, MDLive, and Sesame all offer hypertension management and can prescribe losartan to Rhode Island residents following a qualifying visit.

The Rhode Island Department of Health maintains a list of licensed pharmacies at health.ri.gov, which patients can use to verify that a given compounding pharmacy holds a current RI license before filling a compounded prescription [17].

For patients who receive care at a Federally Qualified Health Center (FQHC) in Rhode Island (such as Providence Community Health Centers or Thundermist Health Center), the 340B Drug Pricing Program applies [22]. Under 340B, eligible FQHCs acquire covered outpatient drugs at significantly reduced prices and pass those savings to uninsured or low-income patients. Losartan is a covered outpatient drug under 340B. A patient filling a losartan prescription through a 340B-registered FQHC pharmacy may pay $0 to $5 per month [22].